Related Experiment Video

Updated: Mar 13, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

890

Targeting p38 MAP kinase signaling in cancer through post-translational modifications

Xiao Zou1, Michael Blank1

  • 1Laboratory of Molecular and Cellular Cancer Biology, Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Cancer Letters
|November 7, 2016
PubMed

Insights

The p38 MAPK pathway plays a complex role in cancer, sometimes hindering and sometimes helping tumor growth. Post-translational modifications (PTMs) on this pathway are increasingly recognized but largely uncharacterized in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Signaling Pathways
  • Proteomics

Background:

  • The p38 Mitogen-Activated Protein Kinase (MAPK) signaling pathway is crucial for cancer cells to respond to environmental cues.
  • This pathway is a significant therapeutic target, but its dual role in promoting or suppressing tumor progression complicates treatment strategies.
  • Emerging research indicates that post-translational modifications (PTMs) significantly regulate p38 MAPK signaling.

Purpose of the Study:

  • To review current research on post-translational modifications (PTMs) within the p38 MAPK signaling pathway.
  • To discuss the complexity and implications of these PTMs in the context of cancer signaling and regulation.
  • To highlight the uncharacterized nature of many PTMs and their biological significance in cancer.

Main Methods:

  • Literature review of studies focusing on PTMs in the p38 MAPK cascade.
  • Analysis of findings from large-scale proteomics profiling of p38 pathway components.
  • Synthesis of information regarding the regulatory roles and biological significance of identified PTMs.

Main Results:

  • Numerous PTMs have been identified on key proteins within the p38 MAPK pathway through recent proteomics studies.
  • The majority of these identified PTMs and their specific functions in cancer remain largely unknown.
  • PTMs add a layer of complexity to the regulation of p38 MAPK signaling, influencing its context-dependent roles.

Conclusions:

  • Post-translational modifications (PTMs) are critical regulators of the p38 MAPK pathway in cancer.
  • Further research is needed to characterize the functional significance of these PTMs for developing targeted cancer therapies.
  • Understanding PTMs is essential for deciphering the complex and context-dependent roles of p38 MAPK signaling in oncology.
Keywords:
CancerChemotherapyPTMUbiquitinationp38 MAPK signaling pathway

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.5K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K